title: Prostaglandin synthesis blockade by ketoprofen attenuates respiratory and cardiovascular responses to static handgrip.
abstract: We investigated the effects of prostaglandin synthesis blockade on the changes in breathing pattern, mean blood pressure (MBP), and heart rate (HR) elicited by 3 min of static handgrip at 30% of the maximum voluntary contraction in 12 healthy volunteers. Before each handgrip trial, subjects were treated with intravenous administration of either saline placebo (control) or 1 mg/kg of ketoprofen. Muscle tension and integrated electromyographic activity of exercising muscles remained fairly constant during each trial. In agreement with our earlier findings, during control handgrip minute ventilation progressively increased (P < 0.01) due to a rise in tidal volume and, to a lesser extent, in respiratory frequency. Mean inspiratory flow, MBP, and HR also increased (P < 0.01). End-tidal PCO2 decreased (P < 0.05) during the late phases of control handgrip bouts. Ketoprofen administration reduced serum thromboxane B2 levels (from 57.5 +/- 7.0 to 1.6 +/- 0.4 pg/ml; P < 0.01) and significantly attenuated mean increases in minute ventilation (40.25 +/- 0.60%), tidal volume (37.78 +/- 7.48%), respiratory frequency (55.94 +/- 17.92%), inspiratory flow (42.66 +/- 5.11%), MBP (22.33 +/- 6.82%), and HR (11.04 +/- 2.75%) during the 3rd min of handgrip. End-tidal PCO2 remained close to normocapnic levels. In agreement with previous animal investigations, the present results show that arachidonic acid metabolites are involved in the regulation of the cardiovascular responses to static efforts in humans, possibly through a stimulatory action on muscle receptors. Furthermore, they provide the first experimental evidence that products of the cyclooxygenase metabolic pathway play a role in the mediation of the respiratory adjustments elicited by this form of exercise.
authors.affiliation: Dipartimento di Fisiopatologia Clinica, Università di Firenze, Italy.
authors.forename: G A
authors.initials: GA
authors.lastname: Fontana
authors.forename: T
authors.initials: T
authors.lastname: Pantaleo
authors.forename: F
authors.initials: F
authors.lastname: Bongianni
authors.forename: F
authors.initials: F
authors.lastname: Cresci
authors.forename: F
authors.initials: F
authors.lastname: Lavorini
authors.forename: C T
authors.initials: CT
authors.lastname: Guerra
authors.forename: P
authors.initials: P
authors.lastname: Panuccio
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D004576:Electromyography; D006225:Hand / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007660:Ketoprofen / Q000494:pharmacology*; D008297:Male; D005082:Physical Exertion / Q000502:physiology*; D011453:Prostaglandins / Q000096:biosynthesis*; D015656:Respiratory Mechanics / Q000187:drug effects*
chemical_list: D016861:Cyclooxygenase Inhibitors; D011453:Prostaglandins; D002245:Carbon Dioxide; D007660:Ketoprofen